Lonza announces first GMP batch completion at next-generation mammalian manufacturing facility in US
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
Dr. Muthu was last associated with Mankind Pharma
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
He specializes in financial planning, audit, compliance and ERP implementation, with extensive experience in leading automation and risk management projects
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power
Subscribe To Our Newsletter & Stay Updated